Xilong Scientific Co., Ltd. (SHE:002584)
China · Delayed Price · Currency is CNY 8.76
-0.36 (-3.95%)
Jul 10, 2026, 3:00 PM CST
Xilong Scientific Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -72.15 | -75.49 | 61.77 | 33.35 | 89.06 | 187.06 |
Depreciation & Amortization | 67.01 | 67.01 | 57.53 | 49.3 | 44.46 | 34.78 |
Other Amortization | 13.22 | 13.22 | 3.67 | 2.58 | 3.33 | 2.59 |
Loss (Gain) From Sale of Assets | 0.48 | 0.48 | 0.84 | 0.21 | 0.14 | 0.39 |
Asset Writedown & Restructuring Costs | 0.16 | 0.16 | 6.3 | 7.04 | 1.47 | -0.34 |
Loss (Gain) From Sale of Investments | 10.8 | 10.8 | -1.22 | -1.05 | -82.97 | -133.82 |
Provision & Write-off of Bad Debts | 28.51 | 28.51 | 11.48 | 8.34 | 12.79 | 20 |
Other Operating Activities | -256.78 | 55.25 | 83.55 | 86.08 | 90.75 | 103.3 |
Change in Accounts Receivable | -76.27 | -76.27 | 104.2 | -105.93 | -492.12 | -73.94 |
Change in Inventory | -27 | -27 | -60.9 | -49.14 | -114.52 | 236.08 |
Change in Accounts Payable | 75.3 | 75.3 | 46.48 | -319.34 | 258.44 | -9.45 |
Change in Other Net Operating Assets | 1.52 | 1.52 | -4.51 | 4.02 | -3.42 | 7.74 |
Operating Cash Flow | -239.32 | 69.36 | 302.16 | -284.71 | -190.88 | 372.99 |
Operating Cash Flow Growth | - | -77.04% | - | - | - | 736.85% |
Capital Expenditures | -104.52 | -100.12 | -44.94 | -215.25 | -323.71 | -56.73 |
Sale of Property, Plant & Equipment | 1.33 | 0.88 | 1.54 | 6.52 | 2.22 | 4.29 |
Cash Acquisitions | - | - | - | - | - | 0.03 |
Divestitures | -5 | - | - | - | 399.22 | 118.99 |
Investment in Securities | 7.12 | 10.8 | -65.19 | 348.26 | -388.12 | -70.03 |
Other Investing Activities | 10.81 | -0.19 | -12.7 | - | -14.26 | - |
Investing Cash Flow | -90.27 | -88.63 | -121.29 | 139.53 | -324.65 | -3.45 |
Short-Term Debt Issued | - | 218.45 | 0.76 | 17.81 | 37.64 | - |
Long-Term Debt Issued | - | 899.4 | 1,117 | 1,353 | 1,368 | 727 |
Total Debt Issued | 1,313 | 1,118 | 1,118 | 1,370 | 1,406 | 727 |
Long-Term Debt Repaid | - | -917.89 | -1,177 | -1,291 | -1,034 | -1,084 |
Total Debt Repaid | -970.29 | -917.89 | -1,177 | -1,291 | -1,034 | -1,084 |
Net Debt Issued (Repaid) | 342.24 | 199.97 | -58.75 | 79.2 | 371.24 | -356.96 |
Common Dividends Paid | -47.8 | -47.8 | -83.27 | -49.98 | -43.18 | -51.66 |
Other Financing Activities | 141.71 | 5.87 | -7.05 | -59.35 | 6.47 | 65.08 |
Financing Cash Flow | 436.15 | 158.04 | -149.07 | -30.12 | 334.53 | -343.54 |
Foreign Exchange Rate Adjustments | 0.06 | 0.06 | -3.27 | -4.31 | -9.04 | 1.61 |
Net Cash Flow | 106.62 | 138.83 | 28.53 | -179.62 | -190.03 | 27.61 |
Free Cash Flow | -343.85 | -30.75 | 257.23 | -499.96 | -514.59 | 316.27 |
Free Cash Flow Growth | - | - | - | - | - | 4898.64% |
Free Cash Flow Margin | -4.63% | -0.42% | 3.29% | -7.05% | -8.32% | 5.88% |
Free Cash Flow Per Share | -0.67 | -0.05 | 0.46 | -0.90 | -0.87 | 0.59 |
Cash Interest Paid | 8.3 | 3.35 | - | - | - | - |
Cash Income Tax Paid | 73.81 | 83.29 | 89.04 | 86.22 | 76.33 | 115.98 |
Levered Free Cash Flow | -388.03 | -89.66 | 208.03 | -547.68 | -310.66 | -73.98 |
Unlevered Free Cash Flow | -354.53 | -59.26 | 236.91 | -509.64 | -279.99 | -31.8 |
Change in Working Capital | -30.58 | -30.58 | 78.25 | -470.56 | -349.93 | 159.02 |